US$ 25.83
foxo4 dri nct eXoZymes (Nasdaq: EXOZ) is targeting metabolic dysfunction a layer deeper than appetite. In a recent Webull webinar, Chief Commercial Officer Damien Perriman walked investors through NCT, the company's first proof point. eXoZymes FOXO4-DRI (10mg) – True Lab
Description
When the blood plasma becomes less concentrated and the level of ADH decreases, aquaporins are removed from collecting tubule cell membranes, and the passage of water out of urine and into the blood decreases

I felt a little woozy and nauseous

Lack of robust human clinical trials prevents confirmation of consistent outcomes, optimal dosing, or long-term safety

When to Call a Doctor Instead of Trying Peptides Some symptoms should not be managed with peptides, supplements, or self-care